Efficacy and safety of intraperitoneal chemotherapy in patients with advanced gastric cancer: a cumulative meta-analysis of randomized controlled trials

Zheng He(First Hospital of China Medical University), Zhi‐Feng Miao(Kaohsiung Medical University), Songcheng Yin(Sun Yat-sen University), Zhongran Ni(University of Technology Sydney), Yingying Xu(Wannan Medical College), Huimian Xu(First Hospital of China Medical University), Xingyu Liu(Tongji Hospital), Hao Xu(Lianyungang Maternal and Children’s Hospital), Tingting Zhao(Lanzhou University Second Hospital), Yongxi Song(First Hospital of China Medical University)
Oncotarget
September 11, 2017
10.18632/oncotarget.20818
Cited by 10

Related Papers

The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021
|Cancer Communications|2021|657
Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial
|The Lancet Oncology|2021|436
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2023
|癌症：英文版|2023|412
Biomarkers of aging
|Science China Life Sciences|2023|362
Microenvironment-Responsive Metal-Phenolic Nanozyme Release Platform with Antibacterial, ROS Scavenging, and Osteogenesis for Periodontitis
|ACS Nano|2023|345